Article
Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy
5 Jul 2024
Abstract excerpt
Significant progress has been achieved in understanding Duchenne muscular dystrophy (DMD) mechanisms and developing treatments to slow disease progression. This review article thoroughly assesses primary and secondary DMD therapies, focusing on innovative modalities. The primary therapy addresses the genetic abnormality causing DMD, specifically the absence or reduced expression of dystrophin. Gene replacement...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
